Patents by Inventor Sunny Chopra

Sunny Chopra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable pharmaceutical composition of 5-aza-2?-deoxycitidine
    Patent number: 9669048
    Abstract: Described herein are ready to use, non-aqueous pharmaceutical compositions comprising 5-aza-2?-deoxycitidine and at least one aprotic solvent. The pharmaceutical compositions may further comprise at least one protic solvent. Also described are processes for preparing the pharmaceutical compositions and their use for the treatment of patients suffering from myelodysplastic syndromes.
    Type: Grant
    Filed: October 24, 2013
    Date of Patent: June 6, 2017
    Assignee: Fresenius Kabi Oncology Limited
    Inventors: Dhiraj Khattar, Rajesh Khanna, Sanjay Motwani, Sunny Chopra, Minakshi Garg
  • STABLE PHARMACEUTICAL COMPOSITION OF 5-AZA-2'-DEOXYCITIDINE
    Publication number: 20160166593
    Abstract: Described herein are ready to use, non-aqueous pharmaceutical compositions comprising 5-aza-2?-deoxycitidine and at least one aprotic solvent. The pharmaceutical compositions may further comprise at least one protic solvent. Also described are processes for preparing the pharmaceutical compositions and their use for the treatment of patients suffering from myelodysplastic syndromes.
    Type: Application
    Filed: October 24, 2013
    Publication date: June 16, 2016
    Inventors: Dhiraj KHATTAR, Rajesh KHANNA, Sanjay MOTWANI, Sunny CHOPRA, Minakshi GARG
  • Self emulsifying drug delivery system for a curcuminoid based composition
    Patent number: 8835509
    Abstract: The present invention discloses a pharmaceutical composition in the form of self nano emulsifying drug delivery formulation comprising curcuminoids. The pharmaceutical composition of the present invention shows an enhanced drug loading ability, better stability and an improved bioavailability. The composition of the present invention comprises of a pharmaceutically effective amount of a curcuminoid, an oil phase, a surfactant and a co surfactant.
    Type: Grant
    Filed: April 26, 2011
    Date of Patent: September 16, 2014
    Assignees: Arbro Pharmaceuticals Ltd., Jamia Hamdard (Hamdard University)
    Inventors: Kanchan Kohli, Sunny Chopra, Saurabh Arora, Roop K. Khar, Kolappa K. Pillai
  • LEVETIRACETAM CONTROLLED RELEASE COMPOSITION
    Publication number: 20120003307
    Abstract: The present invention is concerned with controlled release compositions for oral administration comprising levetiracetam; and with processes of preparing such controlled release compositions.
    Type: Application
    Filed: November 26, 2008
    Publication date: January 5, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Namdev M. Kashid, Sunny Chopra, Sumit Madan, Vinod Arora
  • SELF EMULSIFYING DRUG DELIVERY SYSTEM FOR A CURCUMINOID BASED COMPOSITION
    Publication number: 20110294900
    Abstract: The present invention discloses a pharmaceutical composition in the form of self nano emulsifying drug delivery formulation comprising curcuminoids. The pharmaceutical composition of the present invention shows an enhanced drug loading ability, better stability and an improved bioavailability. The composition of the present invention comprises of a pharmaceutically effective amount of a curcuminoid, an oil phase, a surfactant and a co surfactant.
    Type: Application
    Filed: April 26, 2011
    Publication date: December 1, 2011
    Applicants: JAMIA HAMDARD (HAMDARD UNIVERSITY), Arbro Pharmaceuticals Ltd.
    Inventors: Kanchan Kohli, Sunny Chopra, Saurabh Arora, Roop K. Khar, Kolappa K. Pillai